Tue, May 8, 2012
Mon, May 7, 2012
Sat, May 5, 2012
Fri, May 4, 2012
Thu, May 3, 2012
[ Thu, May 03rd 2012 ]: Market Wire
00 p.m. EDT
Wed, May 2, 2012
[ Wed, May 02nd 2012 ]: Market Wire
Location Change
Tue, May 1, 2012
Mon, April 30, 2012
[ Mon, Apr 30th 2012 ]: Market Wire
Hologic to Acquire Gen-Probe
Sun, April 29, 2012
Sat, April 28, 2012
Fri, April 27, 2012
Thu, April 26, 2012
Wed, April 25, 2012
Tue, April 24, 2012

Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012


  Copy link into your clipboard //health-fitness.news-articles.net/content/2012/ .. ncial-results-conference-call-on-may-8-2012.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8,... -- DUBLIN, April 30, 2012 /PRNewswire/ --

Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012

[ ]

DUBLIN, April 30, 2012 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: [ JAZZ ]) today announced that it will host a conference call and live webcast on Tuesday, May 8, 2012 at 4:30 p.m. EDT/9:30 p.m. IST. During the call, company management will provide a business and financial update and review first quarter 2012 results.

A live webcast of the presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at [ www.jazzpharmaceuticals.com ]. Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

Investors may participate in the conference call by dialing 800-573-4842 in the U.S., or 617-224-4327 outside the U.S., and entering passcode 95197533.

An archived version of webcast will be available for at least one week on the Investors section of the company's website at [ www.jazzpharmaceuticals.com ].

About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc (Nasdaq: [ JAZZ ]) is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing and commercializing products that address unmet medical needs.  The company has a diverse portfolio of products in the areas of narcolepsy, pain, psychiatry and women's health.  The company's marketed products in these areas include: Xyrem® (sodium oxybate), Prialt® (ziconotide intrathecal infusion), FazaClo® (clozapine USP) HD and LD, Luvox CR® (fluvoxamine maleate) and Elestrin® (estradiol gel 0.06%).

SOURCE Jazz Pharmaceuticals plc

[ Back to top ]

RELATED LINKS
[ http://www.jazzpharmaceuticals.com ]


Publication Contributing Sources